Editorial for "Preoperative Prediction of Dual-Phenotype Hepatocellular Carcinoma Using Enhanced MRI Radiomics Models"
- PMID: 35986593
- DOI: 10.1002/jmri.28390
Editorial for "Preoperative Prediction of Dual-Phenotype Hepatocellular Carcinoma Using Enhanced MRI Radiomics Models"
Comment on
-
Preoperative Diagnosis of Dual-Phenotype Hepatocellular Carcinoma Using Enhanced MRI Radiomics Models.J Magn Reson Imaging. 2023 Apr;57(4):1185-1196. doi: 10.1002/jmri.28391. Epub 2022 Aug 17. J Magn Reson Imaging. 2023. PMID: 36190656 Clinical Trial.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin 2018;68:7-30.
-
- Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45:529-538.
-
- Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 2016;150:835-853.
-
- Gao Z, Du G, Pang Y, et al. Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors. Medicine 2017;96:e7426.
-
- Huang X, Long L, Wei J. Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis. J Cancer Res Clin Res Oncol 2019;145(12):2995-3003.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
